Merck to acquire US biopharma company Peloton Therapeutics in $2.2bn deal

pharmanewsdaily- July 14, 2019 0

Merck acquisition of Peloton : Pharma giant Merck is set to acquire US biopharma company Peloton Therapeutics in a deal worth up to $2.2 billion, ... Read More

Pixuvri EMA approval : Servier NHL drug secures standard marketing authorization in Europe

pharmanewsdaily- June 13, 2019 0

Pixuvri EMA approval : French pharma company Servier has secured full approval for Pixuvri (pixantrone) from the European Commission (EC) as monotherapy for aggressive non-Hodgkin ... Read More

Pharma giants bag Lynparza EMA approval for metastatic breast cancer

pharmanewsdaily- May 19, 2019 0

Lynparza EMA approval : Pharma giants AstraZeneca and MSD have secured an expansion of the European Medical Agency's (EMA) approval for their poly ADP-ribose polymerase ... Read More

Genentech gets Kadcyla FDA approval for post-surgery treatment of HER2+ EBC

pharmanewsdaily- May 5, 2019 0

Kadcyla FDA approval : Roche subsidiary Genentech has secured approval from the US Food and Drug Administration (FDA) for its breast cancer drug Kadcyla (ado-trastuzumab ... Read More

Ibrance FDA approval : Pfizer breast cancer drug approved for metastatic breast cancer in men

pharmanewsdaily- April 17, 2019 0

New Ibrance FDA approval : The US Food and Drug Administration (FDA) has extended the approval of Pfizer breast cancer drug Ibrance (palbociclib) to cover ... Read More

Roche’s Tecentriq secures FDA approval for small cell lung cancer treatment

pharmanewsdaily- March 30, 2019 0

Roche’s subsidiary, Genentech, has announced a significant breakthrough with the US Food and Drug Administration (FDA) approval of Tecentriq (atezolizumab). This new approval marks a ... Read More

Bexion Pharmaceuticals advances BXQ-350 cancer drug trial with phase 1 part 3 launch

pharmanewsdaily- February 24, 2019 0

Bexion Pharmaceuticals has launched part 3 of its phase 1 clinical trial for BXQ-350, an investigational cancer treatment aimed at advancing the fight against solid ... Read More

EMD Serono facility expansion in Massachusetts set to advance immuno-oncology research

pharmanewsdaily- February 16, 2019 0

German pharmaceutical giant Merck KGaA has announced a significant investment of $70 million to expand its EMD Serono research and development (R&D) facility located in ... Read More

Merck to invest $70m in expansion of US biopharma facility

pharmanewsdaily- February 16, 2019 0

German pharmaceutical giant Merck is set to invest $70 million to expand its EMD Serono research and development (R&D) facility in Billerica, Massachusetts. This major ... Read More

Pfizer’s Vizimpro receives EMA approval recommendation for NSCLC treatment

pharmanewsdaily- February 3, 2019 0

The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has given a significant boost to Pfizer's lung cancer drug, Vizimpro (dacomitinib), ... Read More